SCHEMBL4615296

SCHEMBL4615296

CCOC(=O)COc1ccc(Oc2cccc(C(=O)Cl)c2)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.46
PPARD Q03181 2/20 0.46
ESR1 P03372 1/20 0.46
HPGD P15428 3/20 0.44
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.43
GAA P10253 2/20 0.43
PPARA Q07869 2/20 0.42
KMT2A Q03164 4/20 0.42
MAPT P10636 4/20 0.42
NPSR1 Q6W5P4 2/20 0.41
MEN1 O00255 2/20 0.41
HSD17B10 Q99714 2/20 0.41
CASP1 P29466 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
CASP3 P42574 1/20 0.40
CASP7 P55210 1/20 0.40
CASP9 P55211 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4616043 0.89 NPC1 (0.50) PPARGPPARDESR1HPGDALDH1A1
SCHEMBL4614599 0.83 RAB9A (0.49) PPARGPPARDHPGDALDH1A1KDM4E
SCHEMBL12093638 0.77 ALDH1A1 (0.56) PPARDESR1HPGDALDH1A1KDM4E
SCHEMBL2434899 0.75 ESR1 (0.53) ESR1HPGDALDH1A1KDM4EGAA
SCHEMBL726592 0.73 AKR1C3 (0.62) ALDH1A1KDM4EKMT2AMEN1POLB
SCHEMBL5416139 0.73 CYP1A2 (0.68) ESR1HPGDALDH1A1GAAKMT2A
SCHEMBL29843916 0.72 ESR1 (0.59) ESR1HPGDALDH1A1KDM4EGAA
SCHEMBL9130182 0.72 GAA (0.62) HPGDALDH1A1KDM4EGAAMAPT
SCHEMBL6503348 0.72 ESR1 (0.59) ESR1HPGDALDH1A1KDM4EGAA
SCHEMBL364241 0.72 HPGD (0.56) HPGDALDH1A1KDM4EKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1697304-B1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2008-02-20 EP disclosed
EP-1697304-B1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2008-02-20 EP disclosed
US-20070082907-A1 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (IN) 2007-04-12 US disclosed
US-20070082907-A1 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (IN) 2007-04-12 US disclosed
US-20070082907-A1 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (IN) 2007-04-12 US disclosed
EP-1697304-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2006-09-06 EP disclosed
WO-2005054176-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082907-A1 Peroxisome proliferator activated receptor modulators PPARG, PPARA, PPARD PPARG 1/4885PPARD 3/4885ESR1 2155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.